Please login to the form below

Not currently logged in
Email:
Password:

Premier Research appoints Dr Colin Hayward as European medical director

He will lead the company's European medical affairs and pharmacovigilance operations

US pharma services company Premier Research has appointed Dr Colin Hayward to lead and develop its European medical affairs and pharmacovigilance operations.

He joins the Philadelphia-headquartered firm as European medical director from pharmaceutical medicine consultancy Prism Ideas where he served as director.

Prior to that role, Dr Hayward served at Roche, where he held a series of positions in pharmacovigilance leading up to that of international medical leader. Before that he worked in the UK's NHS in anaesthesia and intensive care.

"Dr Hayward brings medical expertise, clinical knowledge, leadership, and a wealth of experience in key areas important to our customers and will provide an added level of therapeutic insight to Premier's services," said Sue Stansfield, executive vice president, clinical development.

"He will be a tremendous asset for both employees and customers and is a welcome addition to our strong team in Europe."

Stansfield herself also joined Premier Research in January, and in her new role will have global responsibility for leading the company's clinical trial management services.

She has more than 25 years experience in the pharmaceutical and contract research industries, including stints at clinical service organisations PRA, PPD and Quintiles.

25th January 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics